Investigating the role of small DNA viruses in anogenital cancers
Central Laboratory Core
This study is looking at how certain small viruses, like high-risk HPV, might lead to cancers in the genital area, and it's for patients who want to help researchers learn more about these viruses by providing samples for future studies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11183114 on NIH RePORTER |
What this research studies
This research focuses on understanding how small DNA viruses, particularly high-risk human papillomaviruses (HPV), contribute to anogenital cancers. The Central Laboratory Core (CLC) in Seattle will develop and utilize specialized assays to detect and analyze antibodies related to these viruses. By coordinating the collection and management of biological specimens and clinical data, the CLC aims to support various clinical trials and future studies. Patients' samples will be processed and stored for ongoing and future research, enhancing our understanding of cancer mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with anogenital cancers or those at high risk for these conditions.
Not a fit: Patients with cancers unrelated to HPV or small DNA viruses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for patients with anogenital cancers.
How similar studies have performed: Previous research has shown promising results in understanding the role of HPV in cancer, indicating that this approach has potential for success.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Carter, Joseph John — Fred Hutchinson Cancer Center
- Study coordinator: Carter, Joseph John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.